好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Bringing the AAN Neuro-oncology Curriculum to Neurology Residency Programs Through Televideo: A Pilot Study Through the AAN Neuro-oncology Section To Develop and Implement a Neuro-oncology Curriculum Applicable and Accessible to All Adult Neurology Residents
Neuro-oncology
S29 - Neuro-oncology (4:42 PM-4:54 PM)
007

Though the US has nearly 15,000 neurologists, there are only an estimated 285 board-certified neuro-oncologists.  Accordingly, many neurology residents train in programs that do not have designated neuro-oncology rotations, though later may be expected to manage neurologic complications of cancer and diagnosis of new brain tumors.  Our Neuro-Oncology Section developed a curriculum outline of neuro-oncology competencies for neurology residents, which was published on the AAN website.  We aimed to deliver this curriculum remotely to neurology residency programs.  

To develop and implement a Neuro-Oncology curriculum applicable and accessible to all adult Neurology residents.

For the pilot year, two residency programs were selected based on the criteria of not having a neuro-oncologist on faculty and the interest of the program director and chief resident.  The Neuro-Oncology 好色先生 Workgroup collaborated to develop a series of three teaching sessions aligned with the peer-reviewed AAN Neuro-Oncology curriculum on topics of initial work up of brain mass, clinical management of brain tumors and symptoms, and interactive cases. All sessions were delivered remotely through a televideo conferencing platform, with post-session evaluations.

Delivery of the neuro-oncology curriculum by Neuro-Oncologists in the AAN section was feasible and well received by neurology residents.  The information in the curriculum was new to nearly 90% of the residents responding to the evaluation.  Most participants found that the televideo platform was effective for learning.  The speakers were viewed as knowledgeable, the material presented was relevant to a general neurologist and at the right level for residency training.

A novel neurology residency curriculum in neuro-oncology can be delivered successfully through remote teaching by neuro-oncologists, thereby increasing exposure to neuro-oncology in residency programs.  This strategy may be useful for other neurological subspecialties.  We plan to expand our teaching to more programs and develop a sustainable plan for new groups of residents in our participating programs.

Authors/Disclosures
Alissa A. Thomas, MD, FAAN (University of Vermont Medical Center)
PRESENTER
The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Brett J. Theeler, MD, FAAN (Uniformed Services University of the Health Sciences) Dr. Theeler has nothing to disclose.
Lauren Schaff, MD, FAAN (Memorial Sloan Kettering Cancer Center) Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. An immediate family member of Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MichieHamlett Attorneys at Law. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm.
Lauryn Hemminger (Strong Memorial Hospital) Dr. Hemminger has nothing to disclose.
Maya Hrachova, DO (Allina Health) Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics.
Rajiv Magge, MD (Weill Cornell Medicine) Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Medplace. Dr. Magge has received personal compensation in the range of $5,000-$9,999 for serving as a Founding Medical Content Contributor with Roon.
Katherine B. Peters, MD, PhD, FAAN (Duke University Medical Center) Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NuVox Therapeutics. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals.
Nimish A. Mohile, MD, FAAN The institution of Dr. Mohile has received research support from Novocure.